ETF Managers Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

ETF Managers Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-71,942	Closed	-$1.34M	–	869
2022 Q1	$1.34M	Buy	71,942 +345	+0.5%	+$6.21K	0.03%	247
2021 Q4	$1.52M	Sell	71,597 -14,259	-17%	-$281K	0.03%	236
2021 Q3	$1.57M	Buy	85,856 +16,549	+24%	+$333K	0.03%	224
2021 Q2	$1.5M	Buy	69,307 +689	+1%	+$14K	0.02%	250
2021 Q1	$1.3M	Buy	+68,618	New	+$1.21M	0.02%	245

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ETF Managers Group's OCDX Position: Q2 2022 in Review

ETF Managers Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 71,942 shares — an estimated $1.34M sold.

ETF Managers Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $1.57M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

ETF Managers Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
ETF Managers Group sold 71,942 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.34M.
ETF Managers Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
ETF Managers Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.57M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.